Recent studies showed that PTPN12 inhibits growth, proliferation, tumorigenicity, and metastatic potential in triple-negative breast cancer [12] and colon cancer [13], and also found to be a prognostic biomarker for esophageal squamous cell carcinoma [14]. This evidence concerns the gene PTPN12 and esophageal squamous cell carcinoma.